- Home
- HOLO vs ALBT Comparison
HOLO vs ALBT Comparison
Compare HOLO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- ALBT
- Stock Information
- Founded
- HOLO 2018
- ALBT 2014
- Country
- HOLO China
- ALBT United States
- Employees
- HOLO N/A
- ALBT N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOLO Technology
- ALBT Health Care
- Exchange
- HOLO Nasdaq
- ALBT Nasdaq
- Market Cap
- HOLO 66.3M
- ALBT 7.4M
- IPO Year
- HOLO N/A
- ALBT N/A
- Fundamental
- Price
- HOLO $5.49
- ALBT $2.68
- Analyst Decision
- HOLO
- ALBT
- Analyst Count
- HOLO 0
- ALBT 0
- Target Price
- HOLO N/A
- ALBT N/A
- AVG Volume (30 Days)
- HOLO 1.5M
- ALBT 77.5K
- Earning Date
- HOLO 08-10-2023
- ALBT 11-11-2025
- Dividend Yield
- HOLO N/A
- ALBT N/A
- EPS Growth
- HOLO N/A
- ALBT N/A
- EPS
- HOLO 13.81
- ALBT N/A
- Revenue
- HOLO $44,840,587.00
- ALBT $1,159,091.00
- Revenue This Year
- HOLO N/A
- ALBT N/A
- Revenue Next Year
- HOLO N/A
- ALBT N/A
- P/E Ratio
- HOLO $0.35
- ALBT N/A
- Revenue Growth
- HOLO 37.10
- ALBT N/A
- 52 Week Low
- HOLO $4.16
- ALBT $1.87
- 52 Week High
- HOLO $375.20
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- HOLO 62.40
- ALBT 53.99
- Support Level
- HOLO $4.42
- ALBT N/A
- Resistance Level
- HOLO $5.25
- ALBT $2.90
- Average True Range (ATR)
- HOLO 0.33
- ALBT 0.18
- MACD
- HOLO 0.12
- ALBT -0.02
- Stochastic Oscillator
- HOLO 94.15
- ALBT 92.54
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.